Literature DB >> 20956421

Highly variable clinical phenotypes of hypomorphic RAG1 mutations.

Elizabeth Mannino Avila1, Gulbu Uzel, Amy Hsu, Joshua D Milner, Maria L Turner, Stefania Pittaluga, Alexandra F Freeman, Steven M Holland.   

Abstract

Hypomorphic mutations that lead to "leaky" severe combined immunodeficiency presentation with partial protein function are increasingly being identified. Mutations in recombination-activating genes (RAGs) 1 and 2 cause immunodeficiency and dysregulation ranging from severe combined immunodeficiency to Omenn syndrome to more mild immunodeficiencies. We report here the cases of 3 patients with hypomorphic RAG1 mutations with distinct presentations. One patient had granulomatous skin disease and disseminated nontuberculous mycobacteria; the second patient presented with predominantly autoimmune manifestations; and the third patient presented with relatively late onset of infections and had isolated T-cell lymphopenia. These disparate and atypical presentations of hypomorphic RAG1 mutations highlight the role of RAG1 in immune function and autoimmunity and expand the disease spectrum linked to these genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956421     DOI: 10.1542/peds.2009-3171

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

1.  Compound heterozygous RAG2 mutations mimicking hyper IgM syndrome.

Authors:  A G L Riccetto; M Buzolin; J F Fernandes; F Traina; M L R Barjas-de-Castro; M T N Silva; J B Oliveira; M M Vilela
Journal:  J Clin Immunol       Date:  2013-10-31       Impact factor: 8.317

2.  Idiopathic CD4 lymphocytopenia: Pathogenesis, etiologies, clinical presentations and treatment strategies.

Authors:  Hale Yarmohammadi; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2017-10       Impact factor: 6.347

Review 3.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection.

Authors:  Cullen M Dutmer; Edwin J Asturias; Christiana Smith; Megan K Dishop; D Scott Schmid; William J Bellini; Irit Tirosh; Yu Nee Lee; Luigi D Notarangelo; Erwin W Gelfand
Journal:  J Clin Immunol       Date:  2015-10-29       Impact factor: 8.317

Review 5.  The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases.

Authors:  Joshua D Milner; Steven M Holland
Journal:  Nat Rev Immunol       Date:  2013-07-26       Impact factor: 53.106

Review 6.  Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.

Authors:  Tami John; Jolan E Walter; Catherina Schuetz; Karin Chen; Roshini S Abraham; Carmem Bonfim; Thomas G Boyce; Avni Y Joshi; Elizabeth Kang; Beatriz Tavares Costa Carvalho; Arash Mahajerin; Diane Nugent; Geetha Puthenveetil; Amit Soni; Helen Su; Morton J Cowan; Luigi Notarangelo; David Buchbinder
Journal:  J Clin Immunol       Date:  2016-08-18       Impact factor: 8.317

Review 7.  Use of Genetic Testing for Primary Immunodeficiency Patients.

Authors:  Jennifer R Heimall; David Hagin; Joud Hajjar; Sarah E Henrickson; Hillary S Hernandez-Trujillo; Yuval Tan; Lisa Kobrynski; Kenneth Paris; Troy R Torgerson; James W Verbsky; Richard L Wasserman; Elena W Y Hsieh; Jack J Blessing; Janet S Chou; Monica G Lawrence; Rebecca A Marsh; Sergio D Rosenzweig; Jordan S Orange; Roshini S Abraham
Journal:  J Clin Immunol       Date:  2018-04-19       Impact factor: 8.317

Review 8.  Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

Review 9.  Human RAG mutations: biochemistry and clinical implications.

Authors:  Luigi D Notarangelo; Min-Sung Kim; Jolan E Walter; Yu Nee Lee
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

10.  Adaptive immunity to murine skin commensals.

Authors:  Wei Shen; Wenqing Li; Julie A Hixon; Nicolas Bouladoux; Yasmine Belkaid; Amiran Dzutzev; Scott K Durum
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.